scholarly journals Changes in extracellular water and left ventricular mass in peritoneal dialysis patients

2021 ◽  
Vol 40 (1) ◽  
pp. 135-142 ◽  
Author(s):  
Theerasak Tangwonglert ◽  
Andrew Davenport
1997 ◽  
Vol 17 (4) ◽  
pp. 353-359 ◽  
Author(s):  
Günter Weiss ◽  
Karl Lhotta ◽  
Gilbert Reibnegger ◽  
Paul König ◽  
Edwin Knapp

Objective To investigate the effects of dialysis procedures on cardiac diastolic function. Design Comparative, nonrandomized matched pair study. Setting Nephrology and cardiology departments at a university hospital. Patients Thirty-four patients on hemodialysis (HD) (n = 17) and continuous ambulatory peritoneal dialysis (CAPD) (n = 17), matched by sex, age, duration of dialysis treatment, and presence/absence of diabetes. Measurements Cardiac function was estimated by means of M-mode, two-dimensional, and spectral Dopplerechocardiography, and results were statisticallyevalu-ated by means of univariate and multivariate analytical procedures. Results Although not statistically significant, trends towards differences between the two patient groups were detected for left ventricular mass (p = 0.083) and parameters of diastolic function (p = 0.079). These differences in left ventricular performance and diastolic function between HD and CAPD patients were also evident when calculating Spearman rank correlation coefficients. Left ventricular mass and diastolic function were closely correlated to each other in all dialysis patients. Moreover, by means of a multivariate analytical procedure (Hotelling T square test), diversities in diastolic function between the two patient groups could be clearly established (p = 0.037), with more impaired diastolic function in HD patients. In addition, cardiac performance was shown to depend to a certain extent on hemoglobin concentration. Conclusion Clear differences in diastolic function and cardiac performance were evident between CAPD and HD patients. From the data of our pilot study, it may be speculated whether decrease of left ventricular mass could be beneficial for the improvement of diastolic function and cardiac hemodynamics in dialysis patients.


2014 ◽  
Vol 81 (03) ◽  
pp. 159-165 ◽  
Author(s):  
Kamal Hassan ◽  
Fadi Hassan ◽  
Dunia Hassan ◽  
Shadia Hassan ◽  
Rabia Edgem ◽  
...  

2011 ◽  
Vol 27 (5) ◽  
pp. 835-841 ◽  
Author(s):  
Pirouz Shamszad ◽  
Timothy C. Slesnick ◽  
E. O’Brian Smith ◽  
Michael D. Taylor ◽  
Daniel I. Feig

2007 ◽  
Vol 27 (6) ◽  
pp. 663-668 ◽  
Author(s):  
Nüket Bavbek ◽  
Hatice Akay ◽  
Mustafa Altay ◽  
Ebru Uz ◽  
Faruk Turgut ◽  
...  

Objective To compare ultrafiltration under continuous ambulatory peritoneal dialysis (CAPD) and automated PD (APD), disclosing potential effects on serum B-type natriuretic peptide (BNP) levels and echocardiographic findings. Patients and Methods This cross-sectional clinical study included 32 patients on CAPD and 30 patients on APD without clinical evidence of heart failure or hemodynamically significant valvular heart disease. Peritoneal equilibration tests, BNP levels, and echocardiographic measurements were performed in each subject. BNP measurements were also performed in 24 healthy control subjects. Results Patients on APD had lower ultrafiltration and higher values of BNP and left ventricular mass index (LVMI) compared with patients on CAPD (respectively: 775 ± 160 vs 850 ± 265 mL, p = 0.01; 253.23 ± 81.64 vs 109.42 ± 25.63 pg/mL, p = 0.001; 185.12 ± 63.50 vs 129.30 ± 40.95 g/m2, p = 0.001). This occurred despite higher mean dialysate glucose concentrations and far more extensive use of icodextrin in the APD group. Conclusion Treatment with APD is associated with higher plasma BNP levels and LVMI compared to CAPD. This may be the result of chronic fluid retention caused by lower ultra-filtration in APD patients.


2002 ◽  
Vol 62 (5) ◽  
pp. 1884-1890 ◽  
Author(s):  
Francesca Mallamaci ◽  
Carmine Zoccali ◽  
Saverio Parlongo ◽  
Giovanni Tripepi ◽  
Francesco A. Benedetto ◽  
...  

2018 ◽  
Vol 25 (4) ◽  
pp. 501-511 ◽  
Author(s):  
Afrim Poniku ◽  
Gani Bajraktari ◽  
Shpend Elezi ◽  
Pranvera Ibrahimi ◽  
Michael Y. Henein

2009 ◽  
Vol 29 (4) ◽  
pp. 443-449 ◽  
Author(s):  
Tansu Sav ◽  
Oktay Oymak ◽  
Mehmet Tugrul Inanc ◽  
Ali Dogan ◽  
Bulent Tokgoz ◽  
...  

Background Hypervolemia is a risk factor for left ventricular hypertrophy and hypertension in peritoneal dialysis patients. Icodextrin improves volume control by increasing ultrafiltration in peritoneal dialysis patients. Aim To examine the effects of twice-daily icodextrin administration on blood pressure and left ventricular hypertrophy in peritoneal dialysis patients with hypervolemia and ultrafiltration failure. Method and Results Administration of icodextrin twice daily resulted in a significant reduction in the left ventricular mass index (LVMI) of patients by the end of the third month ( p < 0.05). The reduction in LVMI was also significant for the once-daily icodextrin group ( p < 0.05). Mean blood pressure of patients receiving icodextrin twice daily was significantly reduced ( p < 0.05). By the end of the third month no significant changes were observed in mean blood pressure of the patients using once-daily icodextrin ( p > 0.05). No statistically significant changes were observed in weekly total creatinine clearances or Kt/V of patients in either group at the end of 3 months (NS). Conclusion Twice-daily icodextrin administration was clinically beneficial as shown by reduced blood pressure and prevention of the progress of left ventricular hypertrophy without causing any decrease in dialysis adequacy or any side effects. The icodextrin metabolite results did not suggest any further increase in their values when comparing once- to twice-daily administration of icodextrin. Although prescription of icodextrin once daily may yield good clinical results in the long term, this study showed that it may be more efficient to use twice-daily icodextrin for at least a specific period for the purpose of obtaining quicker results in patients with ultrafiltration failure, serious hypervolemia, or hard-to-control blood pressure conditions.


Sign in / Sign up

Export Citation Format

Share Document